bosentan anhydrous has been researched along with Headache in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benza, RL; Channick, RN; McLaughlin, VV; Olschewski, H; Robbins, IM; Rubin, LJ; Seeger, W; Tapson, VF; Voswinckel, R | 1 |
Darstein, C; Dingemanse, J; Mitchell, MI; Phillips, DL; Wrishko, RE; Yu, A | 1 |
Birnboeck, H; Eggers, H; Hopfgartner, G; Jonkman, JH; Meyer, J; Schmitt, R; van Marle, S; Viischer, HW; Weber, C | 1 |
3 trial(s) available for bosentan anhydrous and Headache
Article | Year |
---|---|
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Bosentan; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Female; Headache; Humans; Hypertension, Pulmonary; Incidence; Longitudinal Studies; Male; Middle Aged; Nausea; Physical Endurance; Piperazines; Purines; Quality of Life; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Young Adult | 2011 |
Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Area Under Curve; Bosentan; Carbolines; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Fatigue; Headache; Humans; Male; Metabolic Clearance Rate; Middle Aged; Phosphodiesterase Inhibitors; Sulfonamides; Tadalafil | 2008 |
Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers.
Topics: Administration, Oral; Antihypertensive Agents; Area Under Curve; Blood Pressure; Bosentan; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Gastrointestinal Diseases; Headache; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Sulfonamides; Systole | 1999 |